U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07141771) titled 'An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing' on July 31.
Brief Summary: Small-cell lung cancer (SCLC) has a high degree of malignancy and extremely poor prognosis, slow progress in the treatment of ES-SCLC, and a more ideal posterior therapy needs to be explored. This is an I / II, phase umbrella study to explore afterline treatment options following progression of frontline platinum-containing therapy for small cell lung cancer.
This study includes 2 parts:
Part 1 will enroll patients with end of first-line platinum-containing therapy and progression interval of less than 180 d...